ArticleCureus2026

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center.

Avi Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.